Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Website: pfizer.com


  • Good financial results growth rate 98.6% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (2.1%)
  • Dividend yield for the last twelve months 7.0%
  • Free cash flow yield 10.1% (LTM)
  • Share price is 12.5% higher than minimum and 55.4% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (10.7x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: PFE
Share price, USD:  (+1.6%)24.2901
year average price 25.49  


year start price 29.75 2024-09-18

max close price 30.19 2024-10-09

min close price 21.59 2025-04-10

current price 24.29 2025-09-17
Common stocks: 5 615 000 000

Dividend Yield:  7.0%
FCF Yield LTM: 10.1%
EV / LTM EBITDA: 10.7x
EV / EBITDA annualized: 9.8x
Last revenue growth (y/y):  +10.3%
Last growth of EBITDA (y/y):  +186.8%
Historical revenue growth:  -10.3%
Historical growth of EBITDA:  +14.6%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 136 389
Net Debt ($m): 48 865
EV (Enterprise Value): 185 254
EBITDA LTM ($m): 17 323
EV / LTM EBITDA: 10.7x
Price to Book: 1.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-09-16fool.com

3 Things You Need to Know If You Buy Pfizer Today

2025-09-13fool.com

1 Reason Every Investor Should Know About Pfizer (PFE) Stock

2025-09-12nypost.com

Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine

2025-09-12zacks.com

Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects

2025-09-11seekingalpha.com

Pfizer's Comeback Accelerates

2025-09-08reuters.com

Pfizer, partner BioNTech say updated COVID shot shows better immune response

2025-09-07fool.com

Is Pfizer a Millionaire Maker?

2025-09-05seekingalpha.com

Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks

2025-09-04zacks.com

Pfizer's 6.9% Yield & Bullish Signal: A Prime Buying Opportunity?

2025-09-04247wallst.com

Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (September 2025)
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data